2026 NPPES data Internal Medicine Physician NPI 1497785166 MD
Verify on CMS →

SERAFIMA GLOUZGAL, MD

Internal Medicine Physician in RIDGEFIELD, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
9K
Medicare Part D claims · 307 beneficiaries · Internal Medicine Physician avg: 3K
MIPS score
12.9734/100
▼ 70 pts below national avg 83.1 · [object Object]
Industry payments
$295.93
13 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

SERAFIMA GLOUZGAL, MD reported a CMS MIPS final score of 12.9734/100 — below the 83.1 national average — and filed 9,110 Medicare Part D claims in 2023.

12.9734/100
MIPS score · -70 vs avg
9K
Part D claims, 2023
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SERAFIMA GLOUZGAL, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

13 2nd percentile higher than 2% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). This entry sits in this band. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

SERAFIMA GLOUZGAL, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SERAFIMA GLOUZGAL, MD?

Below national average

NPI registry status

Active

Issued 07/05/2006

NPI 1497785166

Primary specialty

Internal Medicine Physician

High-volume

172,858 US NPIs in this specialty

Medicare Part D claims

9,110 235% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

MIPS final score

12.9734/100 70.1266% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in Connecticut

How Internal Medicine Physician compares to other specialties among Connecticut providers

Connecticut providers

Internal Medicine Physician share within Connecticut

1. Internal Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Internal Medicine Physician share within Connecticut

Medicare quality performance — MIPS

SERAFIMA GLOUZGAL, MD's 2023 MIPS final score plotted against the Internal Medicine Physician national average

Below national average
MIPS Final Score
12.9734/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Internal Medicine Physician) — 12.9734/100 vs national avg 83.1

0%100%National avg83%13%
MIPS final score (Internal Medicine Physician) — 12.9734/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SERAFIMA GLOUZGAL, MD appears in the CMS NPPES registry as a Internal Medicine Physician provider holding MD credentials at 38B GROVE ST, RIDGEFIELD, CT, 06877, with a listed phone of (203) 431-1942. NPI 1497785166 was issued on 07/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GLOUZGAL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 9,110 prescription claims written by this provider, covering 307 Medicare beneficiaries and totaling roughly $661K in drug spend, with an opioid prescribing rate of 0.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 12.9734/100 for the 2023 performance year (Quality 0, Cost 43.2447), compared with the national average of 83.1.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

38B GROVE ST
RIDGEFIELD, CT 06877

Provider Details

NPI 1497785166
Specialty Internal Medicine Physician
Credentials MD
Gender Female
NPI Issued 07/05/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

12.9734
Final Score
Avg: 83.1
0
Quality
43.2447
Cost

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SERAFIMA GLOUZGAL, MD. Source: openpaymentsdata.cms.gov.

Total received

$296

Largest payer

PFIZER INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

9,110
Total Claims
$661K
Total Drug Cost
307
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
13,084
Total Day Supply
295,868
Generic Drug Cost
$157K
Opioid Claims
81 (0.9% rate)
Antibiotic Claims
299

Patient Demographics

Average Patient Age
79.2 years
Avg HCC Risk Score
1.47
Gender Split
71% female / 29% male
Age Distribution
<65: 13, 65-74: 94, 75-84: 94, 85+: 106

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SERAFIMA GLOUZGAL, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Atorvastatin Calcium
517
Amlodipine Besylate
454
Levothyroxine Sodium
342
Eliquis
Apixaban
259
Metoprolol Tartrate
257
Trazodone Hcl
257
Escitalopram Oxalate
234
Rosuvastatin Calcium
234
Pantoprazole Sodium
229
Gabapentin
217

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How SERAFIMA GLOUZGAL, MD fits within the Internal Medicine Physician landscape nationally.

172,858
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

SERAFIMA GLOUZGAL, MD's 9,110 claims are above the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as GLOUZGAL.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SERAFIMA GLOUZGAL, MD's specialty?
SERAFIMA GLOUZGAL, MD specializes in Internal Medicine Physician and practices in RIDGEFIELD, Connecticut. Credentials: MD.
How much does SERAFIMA GLOUZGAL, MD prescribe under Medicare Part D?
In 2023, SERAFIMA GLOUZGAL, MD wrote 9,110 Medicare Part D claims totaling $661K in drug costs for 307 beneficiaries.
What is SERAFIMA GLOUZGAL, MD's Medicare quality score?
SERAFIMA GLOUZGAL, MD has a CMS MIPS Final Score of 12.9734/100 (Quality: 0, Cost: 43.2447). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SERAFIMA GLOUZGAL, MD located?
SERAFIMA GLOUZGAL, MD is located at 38B GROVE ST, RIDGEFIELD, CT, 06877. Phone: (203) 431-1942.
What is SERAFIMA GLOUZGAL, MD's NPI number?
SERAFIMA GLOUZGAL, MD's National Provider Identifier (NPI) is 1497785166, issued on 07/05/2006.
Does SERAFIMA GLOUZGAL, MD prescribe opioids?
Yes, SERAFIMA GLOUZGAL, MD had 81 opioid claims in 2023 with an opioid prescribing rate of 0.9%.
How many Internal Medicine Physician providers are there in the US?
There are 172,858 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does SERAFIMA GLOUZGAL, MD prescribe most often?
Based on 2023 Medicare Part D data, SERAFIMA GLOUZGAL, MD's most frequently prescribed drugs include Atorvastatin Calcium, Amlodipine Besylate, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SERAFIMA GLOUZGAL, MD accept Medicare?
SERAFIMA GLOUZGAL, MD appears in CMS Medicare data with 9,110 Part D claims and 307 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SERAFIMA GLOUZGAL, MD's credentials?
SERAFIMA GLOUZGAL, MD's NPI is 1497785166 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology